BLCM

Bellicum Pharmaceuticals, Inc.
BLCM

Overview Fund Activity
Delisted

BLCM was delisted on the 1st of June, 2023.

Back to rankings

27 hedge funds and large institutions have $7.68M invested in Bellicum Pharmaceuticals, Inc. in 2020 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 5 increasing their positions, 6 reducing their positions, and 8 closing their positions.

Holders
27
Holders Change
-2
Holders Change %
-6.9%
% of All Funds
0.55%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
5
Reduced
6
Closed
8
Calls
$3.75M
Puts
$7K
Net Calls
+$3.74M
Net Calls Change
+$1.44M

Top Buyers

1
Principal Financial Group
1
Principal Financial Group
Iowa
$396K
2
BCM
2
Bridgeway Capital Management
Texas
$217K
3
Geode Capital Management
3
Geode Capital Management
Massachusetts
$332K
4
BlackRock
4
BlackRock
New York
$772K
5
UBS Group
5
UBS Group
Switzerland
$77K

Top Sellers

1
NAMA
1
Nikko Asset Management Americas
New York
$0
2
Sumitomo Mitsui Trust Group
2
Sumitomo Mitsui Trust Group
Japan
$0
3
Renaissance Technologies
3
Renaissance Technologies
New York
$1.38M
4
Morgan Stanley
4
Morgan Stanley
New York
$7K
5
SM
5
Sabby Management
Florida
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
SM
26
Sabby Management
Florida
– -$89K -18,927 Closed
Millennium Management
27
Millennium Management
New York
– -$77K -16,521 Closed
Victory Capital Management
28
Victory Capital Management
Texas
– -$8K -1,626 Closed
Bank Julius Baer & Co
29
Bank Julius Baer & Co
Switzerland
– -$1K -214 Closed
Royal Bank of Canada
30
Royal Bank of Canada
Ontario, Canada
– -$1K -200 Closed
1
2